Asia Tech Image Inc. (TPEX:4974)

Ligand Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	4,499	4,393	3,539	4,293	4,191	3,989
Revenue Growth (YoY)	24.84%	24.13%	-17.57%	2.43%	5.06%	4.76%
Cost of Revenue	3,757	3,685	2,962	3,531	3,483	3,282
Gross Profit	742.38	707.98	577.27	762.39	707.96	706.94
Selling, General & Admin	133.76	136.67	121.02	147.7	127.72	114.14
Research & Development	73.88	77.79	64.82	73.77	67.86	61.08
Operating Expenses	207.64	214.46	185.85	221.47	195.58	175.21
Operating Income	534.74	493.52	391.43	540.93	512.39	531.72
Interest Expense	-0.35	-0.39	-0.42	-0.25	-0.32	-0.35
Interest & Investment Income	101.61	111.32	89.06	29.49	11.29	19.93
Currency Exchange Gain (Loss)	34.91	34.91	-0.34	82.86	-25.05	-93.51
Other Non Operating Income (Expenses)	-72.71	12.8	23.16	92.82	19.54	7.14
EBT Excluding Unusual Items	598.21	652.16	502.9	745.84	517.84	464.93
Pretax Income	598.21	652.16	502.9	745.84	517.84	464.93
Income Tax Expense	121.24	123.73	94.04	167.11	92.36	90.68
Net Income	476.96	528.43	408.85	578.73	425.48	374.25
Net Income to Common	476.96	528.43	408.85	578.73	425.48	374.25
Net Income Growth	13.25%	29.25%	-29.35%	36.02%	13.69%	4.58%
Shares Outstanding (Basic)	73	73	73	73	73	73
Shares Outstanding (Diluted)	73	73	74	74	74	74
Shares Change (YoY)	-0.57%	-0.56%	-0.51%	0.22%	0.00%	0.21%
EPS (Basic)	6.58	7.29	5.64	7.98	5.87	5.16
EPS (Diluted)	6.52	7.22	5.56	7.83	5.77	5.07
EPS Growth	13.81%	29.86%	-28.99%	35.70%	13.81%	4.32%
Free Cash Flow	428.08	650.78	527.66	601.65	174.88	548.29
Free Cash Flow Per Share	5.86	8.90	7.17	8.14	2.37	7.43
Dividend Per Share	5.450	5.450	4.200	5.800	4.300	3.500
Dividend Growth	29.76%	29.76%	-27.59%	34.88%	22.86%	6.06%
Gross Margin	16.50%	16.12%	16.31%	17.76%	16.89%	17.72%
Operating Margin	11.89%	11.23%	11.06%	12.60%	12.22%	13.33%
Profit Margin	10.60%	12.03%	11.55%	13.48%	10.15%	9.38%
Free Cash Flow Margin	9.52%	14.81%	14.91%	14.01%	4.17%	13.74%
EBITDA	618.15	579.56	482.53	641.89	593.43	597.57
EBITDA Margin	13.74%	13.19%	13.63%	14.95%	14.16%	14.98%
D&A For EBITDA	83.41	86.04	91.1	100.96	81.04	65.85
EBIT	534.74	493.52	391.43	540.93	512.39	531.72
EBIT Margin	11.89%	11.23%	11.06%	12.60%	12.22%	13.33%
Effective Tax Rate	20.27%	18.97%	18.70%	22.41%	17.84%	19.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.